Hard to fault the Science; In comparison, ref to Edwards; ‘The Sapien 3 Ultra platform continues to be differed with low complications, as well as ease-of-use and significant length-of stay efficiency’.
Anteris IP seemingly not only on par with that BUT exceeding the last two. On the issue of low complications; anti calc and durability the benchmark in the market, question is; is there any ‘bugs’ that need to be overcome?, not sure if this is correct but is there any ‘leakage’ problems for example.
Problem then is what? ..... in the execution of realizing this science to its commercial potential?
Imo, not advice.
Good Article in '********* Breakfast', today, page-5
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.00 |
Change
0.800(6.06%) |
Mkt cap ! $295.9M | |||
| Open | High | Low | Value | Volume |
| $13.08 | $14.00 | $12.84 | $202.5K | 15.04K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 88 | $13.20 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.00 | 1109 | 2 |
View Market Depth
| Last trade - 16.10pm 29/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |